E-LIB Suche - Ergebnisse für: Zahir, Hamim

1

Relative Bioavailability of Omaveloxolone When Capsules Are..:

Hynes, Scott M. ; Goldsberry, Angie ; Henneghan, Patrick D....
The Journal of Clinical Pharmacology. , 2024

Link: https://doi.org/10.1002/..

2

Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban ..:

Zou, Peng ; Zahir, Hamim ; Duggal, Anil...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

3

Dosing Recommendation Based on the Effects of Different Mea..:

Zahir, Hamim ; Yin, Ophelia ; Hsu, Ching...
Clinical Pharmacology in Drug Development. 12 (2023) 5 - p. 475-483 , 2023

Link: https://doi.org/10.1002/..

4

Effect of Mild and Moderate Hepatic Impairment (Defined by ..:

Zahir, Hamim ; Greenberg, Jonathan ; Hsu, Ching...
The Journal of Clinical Pharmacology. 62 (2022) 8 - p. 992-1005 , 2022

Link: https://doi.org/10.1002/..

5

Evaluation of Absorption and Metabolism-Based DDI Potential..:

Zahir, Hamim ; Greenberg, Jonathan ; Shuster, Dale...
Clinical Pharmacokinetics. 61 (2022) 11 - p. 1623-1639 , 2022

Link: https://doi.org/10.1007/..

6

Pharmacokinetics of the Multi‐kinase Inhibitor Pexidartinib..:

Zahir, Hamim ; Greenberg, Jonathan ; Hsu, Ching...
Clinical Pharmacology in Drug Development. 12 (2022) 2 - p. 159-167 , 2022

Link: https://doi.org/10.1002/..

7

Phase I studies of the safety, tolerability, pharmacokineti..:

Maruyama, Sonomi ; Visser, Hester ; Ito, Takashi...
Clinical and Translational Science. 15 (2022) 4 - p. 967-980 , 2022

Link: https://doi.org/10.1111/..

8

Exposure–response analysis of efficacy and safety for pexid..:

Yin, Ophelia ; Zahir, Hamim ; French, Jonathan...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 11 - p. 1422-1432 , 2021

Link: https://doi.org/10.1002/..

9

Population Pharmacokinetic Analysis of Pexidartinib in Heal..:

Yin, Ophelia ; Wagner, Andrew J. ; Kang, Jia...
The Journal of Clinical Pharmacology. 61 (2020) 4 - p. 480-492 , 2020

Link: https://doi.org/10.1002/..

10

Evaluation of Potential Drug‐Drug Interaction Risk of Pexid..:

Zahir, Hamim ; Kobayashi, Fumiaki ; Zamora, Cynthia...
The Journal of Clinical Pharmacology. 61 (2020) 3 - p. 298-306 , 2020

Link: https://doi.org/10.1002/..

11

Abuse potential of mirogabalin in recreational polydrug use..:

Mendell, Jeanne ; Levy-Cooperman, Naama ; Sellers, Ed...
Therapeutic Advances in Drug Safety. 10 (2019) - p. 204209861983603 , 2019

Link: https://doi.org/10.1177/..

12

Effect of coadministration of metformin with mirogabalin: R..:

Dow, James ; Currie, Alexander ; He, Ling..
Int. Journal of Clinical Pharmacology and Therapeutics. 56 (2018) 10 - p. 451-458 , 2018

Link: https://doi.org/10.5414/..

13

Coadministration of probenecid and cimetidine with mirogaba..:

Tachibana, Masaya ; Yamamura, Naotoshi ; Atiee, George J....
British Journal of Clinical Pharmacology. 84 (2018) 10 - p. 2317-2324 , 2018

Link: https://doi.org/10.1111/..

14

Tolerability, pharmacokinetics, and pharmacodynamics of mir..:

Brown, Karen ; Mendell, Jeanne ; Ohwada, Shoichi...
Pharmacology Research & Perspectives. 6 (2018) 5 - p. , 2018

Link: https://doi.org/10.1002/..

15

Open-Label Single-Dose Study to Assess the Effect of Mild a..:

Duchin, Kenneth ; Senaldi, Giorgio ; Warren, Vance...
Clinical Drug Investigation. 38 (2018) 11 - p. 1001-1009 , 2018

Link: https://doi.org/10.1007/..